Messages by Thread
-
-
[CML] Pic Of The Day | May 19, 2005
Rob
-
[CML] Warning on enlarged heart
avisallen
-
[CML] Relative importance of apoptosis and cell cycle blockage in the synergistic effect of combined R115777 and imatinib treatment in BCR/ABL-positive cell lines
Rob
-
[CML] Cost Effectiveness of Imatinib Compared with Interferon-alpha or Hydroxycarbamide for First-Line Treatment of Chronic Myeloid Leukaemia
Rob
-
[CML] Cardiac manifestations of the idiopathic hypereosinophilic syndrome
Rob
-
[CML] Lonafarnib reduces the resistance of primitive quiescent CML cells to imatinib mesylate in vitro
Rob
-
[CML] Day 100 has finaly arrived
Dane
-
[CML] Pic Of The Day | May 18, 2005
Rob
-
[CML] Xanthus Presents at ASCO: Phase 1 Data Shows Significant Activity of Amonafide in Combination With ara-C for Treatment of Poor Risk AML
[email protected]
-
[CML] RE: Going Home
Lisa Martinez
-
[CML] Pic Of The Day | May 17, 2005
Rob
-
[CML] Going Home!
Dane
-
[CML] Nancy and Bob
Libby Scrivner
-
[CML] Drug tested on blood disorder might fix genes
[email protected]
-
[CML] Pic Of The Day | May 16, 2005
Rob
-
[CML] Kosan Presents Phase I Results on KOS-953
Rob
-
[CML] Pic Of The Day | May 15, 2005
Rob
-
[CML] Partnership for Prescription Assistance
Rob
-
[CML] Bob W's vertebroplasty
nancy wilhelm
-
[CML] Pic Of The Day | May 14, 2005
Rob
-
[CML] Cancer Drugs On The Way, But Who Pays?
Rob
-
[CML] pcr test results
skink1100
-
[CML] Lymph Node Question
Libby Scrivner
-
[CML] Myelodysplasic syndromes: A comprehensive review
Rob
-
[CML] DRUG MAKERS AIM FOR A BULL'S-EYE - Firms such as Bristol-Myers Squibb focus on targeted therapies
Rob
-
[CML] Dispatches from the War on Cancer
Rob
-
[CML] gleevec side effects
John Barrons
-
[CML] Pic Of The Day | May 13, 2005
Rob
-
[CML] Pic Of The Day | May 12, 2005
Rob
-
[CML] CML Articles With No Abstract
Rob
-
[CML] Do children have increased susceptibility for developing secondary acute myelogenous leukemia?
Rob
-
[CML] Unilateral testicular mass in man with chronic myelomonocytic leukemia: unusual presentation of chronic myelomonocytic leukemia sequela
Rob
-
[CML] Resistance to tyrosine kinase inhibitors: Calling on extra forces
Rob
-
[CML] Imatinib mesylate (Gleevec) downregulates telomerase activity and inhibits proliferation in telomerase-expressing cell lines.
Rob
-
[CML] Pterostilbene and 3'-hydroxypterostilbene are effective apoptosis-inducing agents in MDR and BCR-ABL-expressing leukemia cells
Rob
-
[CML] Phase II Study of Low-Dose Decitabine in Patients With Chronic Myelogenous Leukemia Resistant to Imatinib Mesylate
Rob
-
[CML] Pharmacokinetics of imatinib mesylate in end stage renal disease. A case study
Rob
-
[CML] RE: Eye bleeding-
Lisa Martinez
-
[CML] Poll on CML diagnosis
Barbara Meunier
-
[CML] Eye bleeding-
mtadros9
-
[CML] Pic Of The Day | May 11, 2005
Rob
-
[CML] Dane's Digital Moments 5/10
Dane
-
[CML] New poll for CML
CML
-
[CML] help needed
amit sharma
-
[CML] Pic Of The Day | May 10, 2005
Rob
-
[CML] Houston
avisallen
-
[CML] Dane @ BMT +90 and still feeling fine.
Dane
-
[CML] Sequential organ failure predicts mortality of patients with a haematological malignancy needing intensive care
Rob
-
[CML] Inactivation of the tissue inhibitor of metalloproteinases-2 gene by promoter hypermethylation in lymphoid malignancies
Rob
-
[CML] Von Willebrand factor-cleaving protease activity remains at the intermediate level in thrombotic thrombocytopenic purpura.
Rob
-
[CML] Philadelphia-chromosome-positive T-lymphoblastic leukemia: acute leukemia or chronic myelogenous leukemia blastic crisis
Rob
-
[CML] Nucleophosmin mutations in childhood acute myelogenous leukemia with normal karyotype
Rob
-
[CML] Expression of c-Fes Protein Isoforms Correlates with Differentiation in Myeloid Leukemias
Rob
-
[CML] Intensive treatment and stem cell transplantation in chronic myelogenous leukemia: long-term follow-up
Rob
-
[CML] Laboratory Model of Immune System Overcomes Ethical Constraints on Studies of Hematopoietic Stem Cells in Humans
[email protected]
-
[CML] amit sharma /
eddy mechelaere
-
[CML] Drug Could Augment or Replace Gleevec Positive Results Seen for Chronic Myeloid Leukemia (CML)
Rob
-
[CML] CML book
Lindsey Bott
-
[CML] help needed..
amit sharma
-
[CML] Pic Of The Day | May 09, 2005
Rob
-
[CML] Elizabeth of the UK group
Rob
-
[CML] Pic Of The Day | May 08, 2005
Rob
-
[CML] India, Ukraine to sign MoU for stem cells research
[email protected]
-
[CML] Genetic alterations related to a group of leukemias
[email protected]
-
[CML] Dane's Digital Moments 5/7
Dane
-
[CML] Pharma, patents and the Indian patient
Rob
-
[CML] New Quantative PCR results
mtadros9
-
[CML] Pic Of The Day | May 07, 2005
Rob
-
[CML] Re: Side effects of Gleevec
eagledove605
-
[CML] Dane's Digital Moments 5/6
Dane
-
[CML] Having A Ball
Rob
-
[CML] Pic Of The Day | May 06, 2005
Rob
-
[CML] International cord blood transplant symposium June 3-4 2005 in Los Angeles
[email protected]
-
[CML] Acetaminophen Use May Be Associated With Increased Risk of Asthma and COPD
[email protected]
-
[CML] New comer
Luning Zhang
-
[CML] Cancer Drugs To Watch - Forbes.com
Rob
-
[CML] Thalidomide Petition Seeks Warning on Anticancer Medication
[email protected]
-
[CML] Side effects of gleevec
John Barrons
-
[CML] Pic Of The Day | May 05, 2005
Rob
-
[CML] Denbinobin-mediated anticancer effect in human K562 leukemia cells: role in tubulin polymerization and Bcr-Abl activity
Rob
-
[CML] Two new agents effective in Gleevec-resistant CML
Rob
-
[CML] Molecular responses in patients with chronic myelogenous leukemia in chronic phase treated with imatinib mesylate
Rob
-
[CML] Late-onset marrow aplasia due to imatinib in newly diagnosed chronic phase chronic myeloid leukaemia
Rob
-
[CML] Patients With Up-Front Cytogenetic Resistance to Imatinib Are Associated With a Greater Likelihood of Progression to Blast Crisis
Rob
-
[CML] new to group
cindycindy813
-
[CML] Hello to you,Dianne
Cynthia Schaefer
-
[CML] Off Gleevec???
drwhonutt
-
[CML] Ocygen Levels Drop During Flight
[email protected]
-
[CML] Hi everyone
hello_nebody
-
[CML] Pic Of The Day | May 04, 2005
Rob
-
[CML] Late-stage drugs faring well: Novartis
Rob
-
[CML] Danes' Digital Moments 5/3/04
Dane
-
[CML] risky trial.....
MJHodor
-
[CML] A very interesting read.......
cmlguy
-
[CML] Pic Of The Day | May 03, 2005
Rob
-
[CML] New Drug PD166326 is nearly 100 times more potent than the current drug imatinib (Gleevec)
Rob
-
[CML] Travel expenses for medical care
[email protected]
-
[CML] Pic Of The Day | May 02, 2005
Rob
-
[CML] Chronic myelogenous leukemia in accelerated phase
Rob
-
[CML] A variant t(8;10;21) in a patient with pathological features mimicking atypical chronic myeloid leukemia
Rob
-
[CML] Durability of molecular remission in chronic myeloid leukemia patients treated with imatinib vs allogeneic stem cell transplantation
Rob
-
[CML] Resistance to farnesyltransferase inhibitors in Bcr/Abl-positive lymphoblastic leukemia by increased expression of a novel ABC transporter homolog ATP11a
Rob
-
[CML] How long will chronic myeloid leukemia patients treated with imatinib mesylate live?
Rob
-
[CML] Hospital Rating Site
[email protected]
-
[CML] Patient Assistance Programs Directory Site
[email protected]
-
[CML] Pic Of The Day | May 01, 2005
Rob
-
[CML] testing
MJHodor
-
[CML] Re: cord blood
spragueafm
-
[CML] Pic Of The Day | April 30, 2005
Rob
-
[CML] Lancet Oncology-free issue
[email protected]
-
[CML] Leukemia won't stop senior's graduation
Rob
-
[CML] Medical costs prove a burden even for some with insurance
Rob
-
[CML] Leukaemia mum's joy as baby born
Rob
-
[CML] Efficacy of imatinib mesylate in a patient with idiopathic hypereosinophilic syndrome and severe heart involvement
Rob
-
[CML] The activation of JAK/STAT signal pathway in hypereosinophilic syndrome and the patients therapeutic response to imatinib
Rob
-
[CML] Role of protein kinase C-delta (PKC-delta) in the generation of the effects of IFN-alpha in chronic myelogenous leukemia cells
Rob
-
[CML] Effect of specific siRNA targeting against bcr-abl chimeric gene on chronic myelogenous leukemia cells
Rob
-
[CML] Telomere length and telomerase activity in the BCR-ABL-transformed murine Pro-B cell line BaF3 is unaffected by treatment with imatinib.
Rob
-
[CML] Welcome to the group you never wanted to join
Cynthia Schaefer
-
[CML] Gleevec after COBRA
Jim Sago
-
[CML] Selected MEDLINE this past month "myeloproliferative"
[email protected]
-
[CML] 3 yrs on gleevec the effects have subsided
Michael
-
[CML] Research and Markets: Providing Update Information
Rob
-
[CML] Cytokinetics, Incorporated Reports First Quarter 2005 Financial
Rob
-
[CML] Pic Of The Day | April 28, 2005
Rob
-
[CML] New Members
Rob
-
Re: [CML] Re: [CMLHope] 76 Days Post BMT----First Setback
MoonQn1
-
[CML] cord blood
pennyam1
-
[CML] response to questions
pennyam1
-
[CML] Pic Of The Day | April 27, 2005
Rob
-
[CML] 3 articles with no abstracts yet
Rob
-
[CML] current problems
pennyam1
-
[CML] Pic Of The Day | April 26, 2005
Rob
-
[CML] BROCCOLI, RED CHILI PEPPER SLOW CANCER
[email protected]